Molecular profiling of cancers is becoming more and more important in the research area of personalized cancer therapy, or precision oncology. Next-generation sequencing (NGS) provides a valuable method for high-throughput applications when many targets and samples need to be multiplexed and screened. However, for very focused applications such as single-analyte or single-gene targets, there is a clear need for fast, simple, and affordable methods for detecting low-level somatic variants. The improved sensitivity achieved using Applied Biosystems Minor Variant Finder Software makes Sanger sequencing an ideal technology for filling this gap.